Convalescent plasma therapy in patients with COVID-19

Fevzi Altuntas¹, Tugce Nur Yigenoglu², Semih Bascı³, Mehmet Sinan Dal⁴, Serdal Korkmaz⁵, Burhan Turgut⁶, Mehmet Ali Erkurt⁷

Affiliations

¹ University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey; Yıldırım Beyazıt University, School of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey. Electronic address: dr.faltuntas@gmail.com.
² University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey. Electronic address: dr.nuryigenoglu@gmail.com.
³ University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey. Electronic address: semih1736@hotmail.com.
⁴ University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey. Electronic address: dr.sinandal@gmail.com.
⁵ University of Health Sciences, Kayseri Training and Research Hospital, Department of Hematology, Kayseri, Turkey. Electronic address: baranserdalkorkmaz@gmail.com.
⁶ Namık Kemal University, School of Medicine, Department of Internal Medicine, Division of Hematology, Tekirdağ, Turkey. Electronic address: burhanturgut@hotmail.com.
⁷ İnönü University, School of Medicine, Department of Internal Medicine, Division of Hematology, Malatya, Turkey. Electronic address: mehmetalierkurt@gmail.com.

PMID: 33277207
PMCID: PMC7676310
DOI: 10.1016/j.transci.2020.103017

Comment

Convalescent plasma therapy in patients with COVID-19

Fevzi Altuntas et al. Transfus Apher Sci. 2021 Feb.

. 2021 Feb;60(1):103017.

doi: 10.1016/j.transci.2020.103017. Epub 2020 Nov 19.

Authors

Fevzi Altuntas¹, Tugce Nur Yigenoglu², Semih Bascı³, Mehmet Sinan Dal⁴, Serdal Korkmaz⁵, Burhan Turgut⁶, Mehmet Ali Erkurt⁷

Affiliations

¹ University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey; Yıldırım Beyazıt University, School of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey. Electronic address: dr.faltuntas@gmail.com.
² University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey. Electronic address: dr.nuryigenoglu@gmail.com.
³ University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey. Electronic address: semih1736@hotmail.com.
⁴ University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology and Bone Marrow Transplantation Center, Ankara, Turkey. Electronic address: dr.sinandal@gmail.com.
⁵ University of Health Sciences, Kayseri Training and Research Hospital, Department of Hematology, Kayseri, Turkey. Electronic address: baranserdalkorkmaz@gmail.com.
⁶ Namık Kemal University, School of Medicine, Department of Internal Medicine, Division of Hematology, Tekirdağ, Turkey. Electronic address: burhanturgut@hotmail.com.
⁷ İnönü University, School of Medicine, Department of Internal Medicine, Division of Hematology, Malatya, Turkey. Electronic address: mehmetalierkurt@gmail.com.

PMID: 33277207
PMCID: PMC7676310
DOI: 10.1016/j.transci.2020.103017

No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declare that they do not have any conflict of interest that could inappropriately influence the present study.

Comment on

Convalescent plasma therapy in patients with COVID-19.
Yiğenoğlu TN, Hacıbekiroğlu T, Berber İ, Dal MS, Baştürk A, Namdaroğlu S, Korkmaz S, Ulas T, Dal T, Erkurt MA, Turgut B, Altuntaş F. Yiğenoğlu TN, et al. J Clin Apher. 2020 Aug;35(4):367-373. doi: 10.1002/jca.21806. Epub 2020 Jul 9. J Clin Apher. 2020. PMID: 32643200 Free PMC article. Review.

References

1. Guan W.J., Ni Z.Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(April 18):1708–1720. - PMC - PubMed
1. Yigenoglu T.N., Ata N., Altuntas F., et al. The outcome of COVID‐19 in patients with hematological malignancy. J Med Virol. 2020:1–6. doi: 10.1002/jmv.26404. - DOI - PMC - PubMed
1. Altuntas F., Ata N., Yigenoglu T.N., Bascı S., Dal M.S., Korkmaz S., et al. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2020;19(September) doi: 10.1016/j.transci.2020.102955. - DOI - PMC - PubMed
1. Cakir B. Convalescent plasma (CP) therapy in patients with COVID-19. Transfus Apher Sci. 2020 - PMC - PubMed
1. Yigenoglu T.N., Hacıbekiroglu T., Berber I., et al. Convalescent plasma therapy in patients with COVID-19. J Clin Apher. 2020:1–7. doi: 10.1002/jca.21806. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Convalescent plasma therapy in patients with COVID-19

Affiliations

Convalescent plasma therapy in patients with COVID-19

Authors

Affiliations

Conflict of interest statement

Comment on

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical